Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
MatchMiner is an open source computational platform developed by the Knowledge Systems Group at Dana-Farber Cancer Institute for matching patient-specific genomic profiles to precision cancer medicine clinical trials. It provides three modes of use—patient centric, trial centric, and genomic centric—to accelerate trial enrollment and maximize potential trial options for all patients.
Sources
pmc.ncbi.nlm.nih.gov shapes more of what AI says about MatchMiner than any other source, at 40% of its citations.
nature.com · arxiv.org · ds.dfci.harvard.edu · parse.gl
The market map
Clinical Trial Feasibility Software →Where AI ranks MatchMiner
